Unbiased Analysis of Today's Healthcare Issues

Value Tools in Managed Care Decision Making

Along with co-authors Jeremy Schafer and Dominic Galante, I have a new paper out in JMCP this month.  The abstract is below, but do read the whole piece here. BACKGROUND: Organizations such as the National Comprehensive Cancer Network, American Society of Clinical Oncology, Institute for Clinical and Economic Review, and Memorial Sloan Kettering have created […]

Read the rest of this entry »

Value frameworks are here: What to do about them?

The Healthcare Economist has been published in this month’s edition of Pharmaceutical Commerce.  The article, titled Value frameworks are here: What to do about them?,  provides a brief overview of the existing value frameworks and describes what steps life sciences company can take to evaluate the value of their innovations.   Value frameworks are here: What to do about […]

Read the rest of this entry »

Are You Just a Number?

That is the abbreviated title of a new commentary on the Forbes blog that I wrote with Tomas Philipson.  The full article is HERE.  An excerpt is below. New value frameworks in health care have emerged due to increasing cost pressures. Although value frameworks can be useful tools, they should be used to complement the […]

Read the rest of this entry »

Value Framework Guidelines

In recent years, a number of organizations have developed value frameworks to assess new treatments.  These organizations include the Institute for Clinical and Economic Review (ICER), Memorial Sloan Kettering Memorial Cancer Center (Drug Abacus), American Society for Clinical Oncologists (ASCO),  National Comprehensive Cancer Network (NCCN), European Society of Medical Oncology (Magnitude of Clinical Benefit Scale). […]

Read the rest of this entry »